Healthcare & Life Sciences
NeurOdys Therapeutics
Netherlands
pre-seed
pre-seed
Stage
1
Investors
About
NeurOdys Therapeutics develops novel small molecules aimed at altering disease progression in neurodegenerative diseases such as Alzheimer's and Parkinson's by using computational modeling and AI-driven drug discovery techniques.
Explore NeurOdys Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.